ACTRN12613000264785招募中2 期
Immunogenicity and Safety of a 13-valent pneumococcal conjugate vaccine in paediatric oncology patients
Te-Yu Hung0 个研究点目标入组 100 人开始时间: 2013年3月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 1 Years 至 18 Years（—）
- 性别
- All
入选标准
- •patients with haematological and solid organ malignancies at Princess Margaret Hospital for Children and currently receiving chemotherapy and/or radiotherapy, or those who have completed chemotherapy or radiotherapy within the last 12 months and have not yet received a PCV 13 booster.
排除标准
- •previous anaphylaxis to Prevenar 13 or any vaccine component, received intravenous immunoglobulin in the 3 months prior to administration of vaccination, and patient with asplenia or conditions known to be associated with hyposplenia.
研究者
相似试验
尚未招募
4 期
Immunogenicity and Safety of Pneumococcal 13-valent Conjugate Vaccine between Weuphoria and Prevnar 13 in Thai Older PeopleHealthy participants with no health conditions or stable chronic diseases.-TCTR20230923001ational Vaccine Institute (NVI)408
已完成
不适用
Study of the immunogenicity of 13-valent pneumococcal conjugate vaccine in high-risk patients who were outside recommended ages for routine vaccinatiohematological malignancies and post hematopoietic stem cell transplantationsJPRN-UMIN000038760Chiba university42
已完成
不适用
Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Korean Elderly PeopleCertain infectious and parasitic diseasesKCT0001963Ewha Womans University100
进行中（未招募）
1 期
Study of a Pneumococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers and InfantsPneumococcal infectionMedDRA version: 21.1Level: PTClassification code 10069578Term: Pneumococcal immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-002146-33-Outside-EU/EEASanofi Pasteur Inc.
进行中（未招募）
3 期
Preventing Invasive Pneumococcal Disease in Children & Adolescents with LeukaemiaImmunogenicity of pneumococcal vaccination in children and adolescents newly diagnosed with Leukaemia, with the aim to protect them from invasive pneumococcal diseaseCancer - Leukaemia - Acute leukaemiaACTRN12609000515291HMRC CCRE in Childhood and Adolescent Immunisation100